Amplifying success in immunotherapy
When harnessed appropriately, the immune system is an extremely potent and specific endogenous anti-tumor mechanism. Our mission is to develop novel, innovative and targeted medicines that augment endogenous anti-tumor immunity to improve outcomes for patients affected by cancer.
Our mission is to develop novel, innovative and targeted medicines that augment endogenous anti-tumour immunity to further improve outcomes for patients affected by cancer.
Leadership
Management Team
Our team brings decades of global expertise, with proven success in therapeutic discovery, preclinical, clinical, regulatory and commercial stages of drug development.
Board
Management is ably supported by an experienced Board of Directors who provide overall governance and strategic guidance.
Scientific and Clinical Advisory Board
Pio Tx is establishing a board of scientific and clinical advisors comprising leading experts in immuno-oncology and cytokine signalling.